FDA approves Internal Fixation Systems subtalar implants.
M2 PHARMA-January 24, 2012-FDA approves Internal Fixation Systems subtalar implants(C)2012 M2 COMMUNICATIONS
24 January 2012 - Internal Fixation Systems (OTCBB:IFIX), a US-based producer of orthopaedics implants, said on Monday that it has received clearance from the US Food and Drug Administration (FDA) to market its subtalar implants in the US.
These implants allow patients suffering from trauma or arthritis to preserve motion at their ankle joints.
IFS currently offers a full line of mini-cannulated screws for small bone fixation as well as a Modular Locking Small Fragment System for treatment of bone fractures and osteotomies.
((Comments on this story may be sent to email@example.com)).END.PUB430>PDJanuary 24, 2012>JNM2 PHARMA.PRICEDATENOT APPLICABLE.DAY